Mouwasat Medical Services Co., one of Saudi Arabia’s largest listed healthcare firms, reported a net profit of SAR 155 million for the first nine months of 2015; marking an 18 percent year-on-year (YOY) decline it attributed to operating costs related to the opening of a new hospital in Riyadh last year and an increase in financial charges.
Item | 9m 2014 | 9m 2015 | Change |
---|---|---|---|
Revenues | 718.26 | 740.14 | 3.0 % |
Gross Income | 361.34 | 333.09 | (7.8 %) |
Operating Income | 180.31 | 174.24 | (3.4 %) |
Net Income | 189.37 | 155.00 | (18.1 %) |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 0.95 | 0.78 | (18.1 %) |
The company’s net profit in Q3-2015 plunged 40 percent YOY to SAR 43 million as a result of gains made from a land sale in the comparative period (Q3-2014).
Item | Q3 2014 | Q3 2015 | Change |
---|---|---|---|
Revenues | 230.47 | 231.63 | 0.5 % |
Gross Income | 113.02 | 98.68 | (12.7 %) |
Operating Income | 54.13 | 49.14 | (9.2 %) |
Net Income | 71.99 | 42.99 | (40.3 %) |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 0.36 | 0.21 | (40.3 %) |
Item | Q2 2015 | Q3 2015 | Change |
---|---|---|---|
Revenues | 255.10 | 231.63 | (9.2 %) |
Gross Income | 115.78 | 98.68 | (14.8 %) |
Operating Income | 63.05 | 49.14 | (22.1 %) |
Net Income | 56.09 | 42.99 | (23.4 %) |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 0.28 | 0.21 | (23.4 %) |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
Q1 2006 | - | - | - | - | - | - | - |
Q2 2006 | - | - | - | - | - | - | - |
Q3 2006 | - | - | - | - | - | - | - |
Q4 2006 | - | - | - | - | - | - | - |
2006 | 342.93 | 28.3 % | 135.46 | 24.8 % | 63.23 | 17.9 % | 0.32 |
Q1 2007 | - | - | - | - | - | - | - |
Q2 2007 | - | - | - | - | - | - | - |
Q3 2007 | - | - | - | - | - | - | - |
Q4 2007 | - | - | - | - | - | - | - |
2007 | 400.67 | 16.8 % | 173.39 | 28.0 % | 88.76 | 40.4 % | 0.44 |
Q1 2008 | 113.83 | - | 52.37 | - | 25.90 | - | 0.13 |
Q2 2008 | 118.48 | - | 53.79 | - | 26.63 | - | 0.13 |
Q3 2008 | 104.92 | - | 47.23 | - | 20.47 | - | 0.10 |
Q4 2008 | 117.32 | - | 47.51 | - | 24.07 | - | 0.12 |
2008 | 454.55 | 13.4 % | 200.90 | 15.9 % | 97.07 | 9.4 % | 0.49 |
Q1 2009 | 124.60 | 9.5 % | 56.25 | 7.4 % | 26.55 | 2.5 % | 0.13 |
Q2 2009 | 140.62 | 18.7 % | 67.77 | 26.0 % | 34.03 | 27.8 % | 0.17 |
Q3 2009 | 115.21 | 9.8 % | 54.05 | 14.4 % | 21.88 | 6.9 % | 0.11 |
Q4 2009 | 137.16 | 16.9 % | 49.94 | 5.1 % | 24.58 | 2.1 % | 0.12 |
2009 | 517.60 | 13.9 % | 228.00 | 13.5 % | 107.04 | 10.3 % | 0.54 |
Q1 2010 | 143.79 | 15.4 % | 68.04 | 21.0 % | 32.37 | 21.9 % | 0.16 |
Q2 2010 | 148.78 | 5.8 % | 71.36 | 5.3 % | 34.77 | 2.2 % | 0.17 |
Q3 2010 | 134.72 | 16.9 % | 63.30 | 17.1 % | 23.14 | 5.8 % | 0.12 |
Q4 2010 | 160.20 | 16.8 % | 74.36 | 48.9 % | 28.28 | 15.1 % | 0.14 |
2010 | 587.49 | 13.5 % | 277.05 | 21.5 % | 118.57 | 10.8 % | 0.59 |
Q1 2011 | 166.82 | 16.0 % | 84.05 | 23.5 % | 39.14 | 20.9 % | 0.20 |
Q2 2011 | 164.93 | 10.9 % | 76.76 | 7.6 % | 40.49 | 16.4 % | 0.20 |
Q3 2011 | 156.92 | 16.5 % | 74.10 | 17.1 % | 33.71 | 45.7 % | 0.17 |
Q4 2011 | 189.77 | 18.5 % | 89.09 | 19.8 % | 34.72 | 22.8 % | 0.17 |
2011 | 678.44 | 15.5 % | 324.00 | 16.9 % | 148.06 | 24.9 % | 0.74 |
Q1 2012 | 195.57 | 17.2 % | 94.32 | 12.2 % | 46.34 | 18.4 % | 0.23 |
Q2 2012 | 200.62 | 21.6 % | 93.28 | 21.5 % | 47.26 | 16.7 % | 0.24 |
Q3 2012 | 187.28 | 19.3 % | 84.01 | 13.4 % | 35.44 | 5.1 % | 0.18 |
Q4 2012 | 213.04 | 12.3 % | 101.10 | 13.5 % | 42.56 | 22.6 % | 0.21 |
2012 | 796.51 | 17.4 % | 372.71 | 15.0 % | 171.60 | 15.9 % | 0.86 |
Q1 2013 | 219.23 | 12.1 % | 110.39 | 17.0 % | 52.52 | 13.3 % | 0.26 |
Q2 2013 | 228.74 | 14.0 % | 116.90 | 25.3 % | 54.16 | 14.6 % | 0.27 |
Q3 2013 | 211.63 | 13.0 % | 104.34 | 24.2 % | 44.11 | 24.5 % | 0.22 |
Q4 2013 | 242.64 | 13.9 % | 124.17 | 22.8 % | 50.42 | 18.4 % | 0.25 |
2013 | 902.24 | 13.3 % | 455.80 | 22.3 % | 201.20 | 17.3 % | 1.01 |
Q1 2014 | 243.54 | 11.1 % | 124.18 | 12.5 % | 57.94 | 10.3 % | 0.29 |
Q2 2014 | 244.25 | 6.8 % | 124.14 | 6.2 % | 59.44 | 9.8 % | 0.30 |
Q3 2014 | 230.47 | 8.9 % | 113.02 | 8.3 % | 71.99 | 63.2 % | 0.36 |
Q4 2014 | 247.18 | 1.9 % | 117.49 | (5.4 %) | 50.75 | 0.7 % | 0.25 |
2014 | 903.79 | 0.2 % | 417.17 | (8.5 %) | 240.12 | 19.3 % | 1.20 |
Q1 2015 | 253.41 | 4.1 % | 118.63 | (4.5 %) | 55.93 | (3.5 %) | 0.28 |
Q2 2015 | 255.10 | 4.4 % | 115.78 | (6.7 %) | 56.09 | (5.6 %) | 0.28 |
Q3 2015 | 231.63 | 0.5 % | 98.68 | (12.7 %) | 42.99 | (40.3 %) | 0.21 |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
2005 | 267.39 | - | 108.50 | - | 53.65 | - | 0.27 |
2006 | 342.93 | 28.3 % | 135.46 | 24.8 % | 63.23 | 17.9 % | 0.32 |
2007 | 400.67 | 16.8 % | 173.39 | 28.0 % | 88.76 | 40.4 % | 0.44 |
2008 | 454.55 | 13.4 % | 200.90 | 15.9 % | 97.07 | 9.4 % | 0.49 |
2009 | 517.60 | 13.9 % | 228.00 | 13.5 % | 107.04 | 10.3 % | 0.54 |
2010 | 587.49 | 13.5 % | 277.05 | 21.5 % | 118.57 | 10.8 % | 0.59 |
2011 | 678.44 | 15.5 % | 324.00 | 16.9 % | 148.06 | 24.9 % | 0.74 |
2012 | 796.51 | 17.4 % | 372.71 | 15.0 % | 171.60 | 15.9 % | 0.86 |
2013 | 902.24 | 13.3 % | 455.80 | 22.3 % | 201.20 | 17.3 % | 1.01 |
2014 | 903.79 | 0.2 % | 417.17 | (8.5 %) | 240.12 | 19.3 % | 1.20 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2006 | - | - | - |
Q2 2006 | - | - | - |
Q3 2006 | - | - | - |
Q4 2006 | - | - | - |
2006 | 39.50 % | 26.05 % | 18.44 % |
Q1 2007 | - | - | - |
Q2 2007 | - | - | - |
Q3 2007 | - | - | - |
Q4 2007 | - | - | - |
2007 | 43.28 % | 31.24 % | 22.15 % |
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | 44.20 % | 30.76 % | 21.36 % |
2008 | 44.20 % | 30.76 % | 21.36 % |
Q1 2009 | 44.01 % | 30.89 % | 21.00 % |
Q2 2009 | 44.88 % | 32.07 % | 21.57 % |
Q3 2009 | 45.32 % | 32.67 % | 21.40 % |
Q4 2009 | 44.05 % | 30.06 % | 20.68 % |
2009 | 44.05 % | 30.06 % | 20.68 % |
Q1 2010 | 44.67 % | 30.72 % | 21.03 % |
Q2 2010 | 44.66 % | 30.02 % | 20.85 % |
Q3 2010 | 44.76 % | 28.94 % | 20.35 % |
Q4 2010 | 47.16 % | 30.15 % | 20.18 % |
2010 | 47.16 % | 30.15 % | 20.18 % |
Q1 2011 | 48.00 % | 29.97 % | 20.53 % |
Q2 2011 | 47.63 % | 29.54 % | 20.91 % |
Q3 2011 | 47.66 % | 30.31 % | 21.83 % |
Q4 2011 | 47.76 % | 30.40 % | 21.82 % |
2011 | 47.76 % | 30.40 % | 21.82 % |
Q1 2012 | 47.27 % | 30.32 % | 21.95 % |
Q2 2012 | 47.22 % | 30.30 % | 21.81 % |
Q3 2012 | 46.65 % | 28.88 % | 21.18 % |
Q4 2012 | 46.79 % | 28.28 % | 21.54 % |
2012 | 46.79 % | 28.28 % | 21.54 % |
Q1 2013 | 47.40 % | 28.13 % | 21.68 % |
Q2 2013 | 48.62 % | 28.20 % | 21.77 % |
Q3 2013 | 49.59 % | 28.72 % | 22.16 % |
Q4 2013 | 50.52 % | 29.11 % | 22.30 % |
2013 | 50.52 % | 29.11 % | 22.30 % |
Q1 2014 | 50.68 % | 28.86 % | 22.30 % |
Q2 2014 | 50.62 % | 28.77 % | 22.49 % |
Q3 2014 | 50.53 % | 28.82 % | 22.70 % |
Q4 2014 | 49.60 % | 28.54 % | 22.40 % |
2014 | 46.16 % | 30.49 % | 23.92 % |
Q1 2015 | 48.53 % | 28.38 % | 21.96 % |
Q2 2015 | 47.14 % | 28.23 % | 21.38 % |
Q3 2015 | 45.64 % | 28.05 % | 20.62 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2005 | 40.58 % | 28.06 % | 20.06 % |
2006 | 39.50 % | 26.05 % | 18.44 % |
2007 | 43.28 % | 31.24 % | 22.15 % |
2008 | 44.20 % | 30.76 % | 21.36 % |
2009 | 44.05 % | 30.06 % | 20.68 % |
2010 | 47.16 % | 30.15 % | 20.18 % |
2011 | 47.76 % | 30.40 % | 21.82 % |
2012 | 46.79 % | 28.28 % | 21.54 % |
2013 | 50.52 % | 29.11 % | 22.30 % |
2014 | 46.16 % | 30.49 % | 23.92 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2006 | - | - | - |
Q2 2006 | - | - | - |
Q3 2006 | - | - | - |
Q4 2006 | - | - | - |
Q1 2007 | - | - | - |
Q2 2007 | - | - | - |
Q3 2007 | - | - | - |
Q4 2007 | - | - | - |
Q1 2008 | 46.01 % | 31.17 % | 22.75 % |
Q2 2008 | 45.40 % | 31.49 % | 22.48 % |
Q3 2008 | 45.02 % | 29.90 % | 19.51 % |
Q4 2008 | 40.49 % | 30.38 % | 20.52 % |
Q1 2009 | 45.14 % | 31.63 % | 21.31 % |
Q2 2009 | 48.19 % | 35.49 % | 24.20 % |
Q3 2009 | 46.91 % | 32.66 % | 18.99 % |
Q4 2009 | 36.41 % | 20.87 % | 17.92 % |
Q1 2010 | 47.32 % | 33.89 % | 22.51 % |
Q2 2010 | 47.96 % | 32.68 % | 23.37 % |
Q3 2010 | 46.98 % | 27.76 % | 17.18 % |
Q4 2010 | 46.42 % | 26.45 % | 17.65 % |
Q1 2011 | 50.38 % | 32.72 % | 23.46 % |
Q2 2011 | 46.54 % | 30.78 % | 24.55 % |
Q3 2011 | 47.22 % | 31.20 % | 21.48 % |
Q4 2011 | 46.95 % | 27.37 % | 18.29 % |
Q1 2012 | 48.23 % | 32.08 % | 23.69 % |
Q2 2012 | 46.49 % | 30.64 % | 23.56 % |
Q3 2012 | 44.86 % | 25.18 % | 18.92 % |
Q4 2012 | 47.46 % | 25.28 % | 19.98 % |
Q1 2013 | 50.35 % | 31.12 % | 23.96 % |
Q2 2013 | 51.11 % | 30.61 % | 23.68 % |
Q3 2013 | 49.30 % | 27.68 % | 20.84 % |
Q4 2013 | 51.18 % | 27.14 % | 20.78 % |
Q1 2014 | 50.99 % | 29.94 % | 23.79 % |
Q2 2014 | 50.83 % | 30.16 % | 24.34 % |
Q3 2014 | 49.04 % | 27.98 % | 21.82 % |
Q4 2014 | 47.53 % | 26.09 % | 19.64 % |
Q1 2015 | 46.81 % | 29.28 % | 22.07 % |
Q2 2015 | 45.38 % | 29.50 % | 21.99 % |
Q3 2015 | 42.60 % | 27.19 % | 18.56 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2006 | - | - | - | - |
Q2 2006 | - | - | - | - |
Q3 2006 | - | - | - | - |
Q4 2006 | - | - | - | - |
Q1 2007 | - | - | - | - |
Q2 2007 | - | - | - | - |
Q3 2007 | - | - | - | - |
Q4 2007 | - | - | - | - |
Q1 2008 | 200.00 | - | - | 1.90 |
Q2 2008 | 200.00 | - | - | 1.92 |
Q3 2008 | 200.00 | - | - | 2.02 |
Q4 2008 | 200.00 | 0.49 | 0.49 | 2.05 |
Q1 2009 | 200.00 | 0.49 | 0.49 | 2.18 |
Q2 2009 | 200.00 | 0.53 | 0.53 | 2.27 |
Q3 2009 | 200.00 | 0.53 | 0.53 | 2.28 |
Q4 2009 | 200.00 | 0.54 | 0.54 | 2.40 |
Q1 2010 | 200.00 | 0.56 | 0.56 | 2.56 |
Q2 2010 | 200.00 | 0.57 | 0.57 | 2.61 |
Q3 2010 | 200.00 | 0.57 | 0.57 | 2.72 |
Q4 2010 | 200.00 | 0.59 | 0.59 | 2.86 |
Q1 2011 | 200.00 | 0.63 | 0.63 | 3.06 |
Q2 2011 | 200.00 | 0.66 | 0.66 | 3.01 |
Q3 2011 | 200.00 | 0.71 | 0.71 | 3.18 |
Q4 2011 | 200.00 | 0.74 | 0.74 | 3.34 |
Q1 2012 | 200.00 | 0.78 | 0.78 | 3.57 |
Q2 2012 | 200.00 | 0.81 | 0.81 | 3.44 |
Q3 2012 | 200.00 | 0.82 | 0.82 | 3.61 |
Q4 2012 | 200.00 | 0.86 | 0.86 | 3.82 |
Q1 2013 | 200.00 | 0.89 | 0.89 | 4.08 |
Q2 2013 | 200.00 | 0.92 | 0.92 | 3.98 |
Q3 2013 | 200.00 | 0.97 | 0.97 | 4.20 |
Q4 2013 | 200.00 | 1.01 | 1.01 | 4.44 |
Q1 2014 | 200.00 | 1.03 | 1.03 | 4.73 |
Q2 2014 | 200.00 | 1.06 | 1.06 | 4.53 |
Q3 2014 | 200.00 | 1.20 | 1.09 | 4.89 |
Q4 2014 | 200.00 | 1.20 | 1.08 | 5.14 |
Q1 2015 | 200.00 | 1.19 | 1.07 | 5.42 |
Q2 2015 | 200.00 | 1.17 | 1.05 | 5.20 |
Q3 2015 | 200.00 | 1.03 | 1.02 | 5.41 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2005 | 200.00 | 0.27 | 0.27 | 1.25 |
2006 | 200.00 | 0.32 | 0.32 | 1.49 |
2007 | 200.00 | 0.44 | 0.44 | 1.77 |
2008 | 200.00 | 0.49 | 0.49 | 2.05 |
2009 | 200.00 | 0.54 | 0.54 | 2.40 |
2010 | 200.00 | 0.59 | 0.59 | 2.86 |
2011 | 200.00 | 0.74 | 0.74 | 3.34 |
2012 | 200.00 | 0.86 | 0.86 | 3.82 |
2013 | 200.00 | 1.01 | 1.01 | 4.44 |
2014 | 200.00 | 1.20 | 1.08 | 5.14 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2006 | - | - | - |
Q2 2006 | - | - | - |
Q3 2006 | - | - | - |
Q4 2006 | - | - | - |
Q1 2007 | - | - | - |
Q2 2007 | - | - | - |
Q3 2007 | - | - | - |
Q4 2007 | - | - | - |
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | 14.20 | 14.20 | 3.31 |
Q4 2009 | 14.31 | 14.31 | 3.19 |
Q1 2010 | 13.68 | 13.68 | 3.02 |
Q2 2010 | 14.64 | 14.64 | 3.19 |
Q3 2010 | 14.75 | 14.75 | 3.11 |
Q4 2010 | 15.18 | 15.18 | 3.15 |
Q1 2011 | 13.52 | 13.52 | 2.77 |
Q2 2011 | 16.08 | 16.08 | 3.50 |
Q3 2011 | 13.29 | 13.29 | 2.96 |
Q4 2011 | 15.92 | 15.92 | 3.53 |
Q1 2012 | 16.83 | 16.83 | 3.66 |
Q2 2012 | 13.89 | 13.89 | 3.27 |
Q3 2012 | 15.57 | 15.57 | 3.53 |
Q4 2012 | 15.66 | 15.66 | 3.52 |
Q1 2013 | 18.00 | 18.00 | 3.92 |
Q2 2013 | 18.62 | 18.62 | 4.32 |
Q3 2013 | 21.21 | 21.21 | 4.88 |
Q4 2013 | 22.86 | 22.86 | 5.18 |
Q1 2014 | 21.78 | 21.78 | 4.75 |
Q2 2014 | 24.19 | 24.19 | 5.66 |
Q3 2014 | 26.21 | 28.82 | 6.43 |
Q4 2014 | 25.71 | 28.55 | 6.01 |
Q1 2015 | 27.98 | 31.11 | 6.15 |
Q2 2015 | 30.38 | 33.83 | 6.86 |
Q3 2015 | 29.89 | 30.21 | 5.68 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2005 | - | - | - |
2006 | - | - | - |
2007 | - | - | - |
2008 | - | - | - |
2009 | 14.31 | 14.31 | 3.19 |
2010 | 15.18 | 15.18 | 3.15 |
2011 | 15.92 | 15.92 | 3.53 |
2012 | 15.66 | 15.66 | 3.52 |
2013 | 22.86 | 22.86 | 5.18 |
2014 | 25.71 | 28.55 | 6.01 |
Q3 2015
2015
Period | Medical Services | Pharmaceutical Products | Administration Fees |
---|---|---|---|
Q1 2008 | 86.60 | 26.81 | 0.43 |
Q2 2008 | 91.71 | 26.38 | 0.40 |
Q3 2008 | 84.21 | 20.23 | 0.47 |
Q4 2008 | 84.07 | 31.65 | 1.61 |
Q1 2009 | 94.61 | 29.63 | 0.36 |
Q2 2009 | 105.22 | 28.44 | 6.97 |
Q3 2009 | 92.73 | 26.15 | (3.67) |
Q4 2009 | 103.72 | 33.04 | 0.40 |
Q1 2010 | 109.41 | 32.47 | 1.92 |
Q2 2010 | 114.73 | 34.05 | - |
Q3 2010 | 102.85 | 31.87 | - |
Q4 2010 | 118.91 | 41.29 | - |
Q1 2011 | 129.63 | 37.19 | - |
Q2 2011 | 128.04 | 36.89 | - |
Q3 2011 | 123.09 | 33.84 | - |
Q4 2011 | 149.24 | 40.52 | - |
Q1 2012 | 155.38 | 40.19 | - |
Q2 2012 | 159.24 | 41.38 | - |
Q3 2012 | 149.51 | 37.77 | - |
Q4 2012 | 168.11 | 44.93 | - |
Q1 2013 | 177.18 | 42.05 | - |
Q2 2013 | 186.71 | 42.02 | - |
Q3 2013 | 172.61 | 39.02 | - |
Q4 2013 | 182.05 | 45.21 | - |
Q1 2014 | 196.67 | 46.87 | - |
Q2 2014 | 198.14 | 46.10 | - |
Q3 2014 | 186.70 | 43.78 | - |
Q4 2014 | 137.05 | 48.48 | - |
Q1 2015 | 201.34 | 52.07 | - |
Q2 2015 | 205.21 | 49.89 | - |
Q3 2015 | 189.98 | 41.65 | - |
Period | Medical Services | Pharmaceutical Products | Administration Fees |
---|---|---|---|
2005 | 218.74 | 46.93 | 1.72 |
2006 | 275.14 | 66.36 | 1.42 |
2007 | 275.14 | 88.92 | 2.32 |
2008 | 346.58 | 105.06 | 2.91 |
2009 | 396.28 | 117.25 | 4.07 |
2010 | 445.90 | 139.68 | 1.92 |
2011 | 530.00 | 148.44 | - |
2012 | 632.24 | 164.27 | - |
2013 | 718.55 | 168.30 | - |
2014 | 718.55 | 185.23 | - |
Item | Q3 2015 (e) | Q3 2015 (a) | Change |
---|---|---|---|
Average | 65.20 | 42.99 | (34.1 %) |
Item | Q3 2015 (e) | Q3 2015 (a) | Change |
---|---|---|---|
SFC | 52.00 | 42.99 | (17.3) % |
Albilad Capital | 58.00 | 42.99 | (25.9) % |
Alistithmar Capital | 70.00 | 42.99 | (38.6) % |
AlJazira Capital | 80.80 | 42.99 | (46.8) % |
Current | |
Market Cap (M Riyal) | 23,440.00 |
Enterprise Value (EV) (M) | 24,206.83 |
Shares Outstanding ((M)) | 200.00 |
EPS ( Riyal) (TTM) | 3.30 |
Book Value (BV) ( Riyal) | 17.24 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 35.56 |
P/E (TTM) | 35.56 |
Price/book | 6.80 |
Return on Average Assets (%) (TTM) | 13.5 |
Return on Average Equity (%) (TTM) | 20.2 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}